These results demonstrated that knocking down ECM1 was sufficient to restore 5-FU sensitivity in 5-FU resistant CRC cells in vivo via altering EMT induction and apoptotic resistance via the PI3K/AKT/GSK3β pathway. This evidence concerns the gene ECM1 and colorectal carcinoma.